Importer of Controlled Substances; Notice of Registration, 799 [2011-12]

Download as PDF Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices Issued: December 30, 2010. Marilyn R. Abbott, Secretary to the Commission. Drug Sufentanil (9740) .......................... [FR Doc. 2010–33355 Filed 1–5–11; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated June 17, 2010, and published in the Federal Register on June 28, 2010, 75 FR 36680, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Cathinone (1235) .......................... Methaqualone (2565) ................... Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... 4-Methyl-2,5dimethoxyamphetamine (7395). 3,4-Methylenedioxyamphetamine (7400). Codeine-n-oxide (9053) ................ Heroin (9200) ............................... Amphetamine (1100) .................... Drug erowe on DSK5CLS3C1PROD with NOTICES I The company plans to import reference standards for sale to researchers and analytical labs. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of United States Pharmacopeial Convention to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated United States Pharmacopeial Convention to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: December 23, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. I I II Dated: December 23, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–11 Filed 1–5–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR [FR Doc. 2011–12 Filed 1–5–11; 8:45 am] II II II II II II II II II II II II II II II II II II II II II BILLING CODE 4410–09–P Employee Benefits Security Administration DEPARTMENT OF JUSTICE Publication of Year 2010 Form M–1 With Electronic Filing Option, Notice Drug Enforcement Administration Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... By Notice dated October 15, 2010, and published in the Federal Register on October 26, 2010, 75 FR 65660, Noramco Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Thebaine (9333) ......................... Tapentadol (9780) ...................... II II II II II The company plans to import Thebaine (9333) analytical reference standards for distribution to its customers. The company plans to Jkt 223001 Employee Benefits Security Administration, Department of Labor. ACTION: Notice on the Availability of the Year 2010 Form M–1 with Electronic Filing Option. AGENCY: Importer of Controlled Substances; Notice of Registration Schedule Drug 15:07 Jan 05, 2011 I I I I I I II import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Noramco Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Noramco Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Schedule Methamphetamine (1105) ............ Phenmetrazine (1631) .................. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Phencyclidine (7471) .................... Alphaprodine (9010) ..................... Anileridine (9020) ......................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). VerDate Mar<15>2010 Schedule 799 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 II II This document announces the availability of the Year 2010 Form M– 1, Annual Report for Multiple Employer Welfare Arrangements and Certain Entities Claiming Exception. It is generally identical to the 2009 Form M– 1, except that a few changes were made to update the Part 7 compliance questions to reflect the current provisions of Part 7 that were effective in 2010. The Form M–1 may again be filed electronically over the Internet. FOR FURTHER INFORMATION CONTACT: For inquiries regarding the Form M–1 filing requirement, contact Amy J. Turner or Beth L. Baum, Office of Health Plan Standards and Compliance Assistance, SUMMARY: E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 76, Number 4 (Thursday, January 6, 2011)]
[Notices]
[Page 799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated June 17, 2010, and published in the Federal 
Register on June 28, 2010, 75 FR 36680, United States Pharmacopeial 
Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methaqualone (2565)........................  I
Lysergic acid diethylamide (7315)..........  I
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
3,4-Methylenedioxyamphetamine (7400).......  I
Codeine-n-oxide (9053).....................  I
Heroin (9200)..............................  I
Amphetamine (1100).........................  II
------------------------------------------------------------------------


------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methamphetamine (1105).....................  II
Phenmetrazine (1631).......................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Phencyclidine (7471).......................  II
Alphaprodine (9010)........................  II
Anileridine (9020).........................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Hydrocodone (9193).........................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
------------------------------------------------------------------------


------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to import reference standards for sale to 
researchers and analytical labs.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of United States Pharmacopeial Convention to import the 
basic classes of controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. DEA has 
investigated United States Pharmacopeial Convention to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-12 Filed 1-5-11; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.